Loading...
(68)Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study
This prospective pilot study investigated the value of (68)Ga-NOTA-RM26, an antagonist targeting gastrin-releasing peptide receptor (GRPR), in evaluation of breast cancer. METHODS: Thirty-five women in suspicion of breast cancer based on mammography or ultrasonography were recruited with informed co...
Na minha lista:
| Udgivet i: | Clin Nucl Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6076351/ https://ncbi.nlm.nih.gov/pubmed/30036253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLU.0000000000002209 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|